Preclinical Mouse Intraductal Model (MIND) to Study Metastatic Dormancy in Estrogen Receptor-Positive Breast Cancer
Authors:
- 23 July 2024
- book chapter
- Published by Springer Nature
- Vol. 2811, 101-112
Abstract
Here, we describe a clinically relevant xenograft model of hormone receptor-positive breast cancer that maintains estrogen receptor (ER) status without the need for exogenous supplementation of hormones. The naturally low 17-β-estradiol levels in host mice recapitulate levels seen in post-menopausal women. By introducing breast cancer cells directly into their “natural” microenvironment of the milk ducts, these cells maintain hormone receptor status, model the clinical progression of the disease, and develop ER− metastatic lesions or dormant micrometastatic lesions in the case of ER+ BC. With the use of GFP/RFP:Luc2 reporters, we can monitor in vivo tumour growth and conduct ex vivo metastases assays to evaluate dormant metastatic cell harboring organs. Upon recovery of metastatic cells from ER+ breast cancer models, downstream analyses can be conducted to assess the relationship between epithelial plasticity and metastatic dormancy.Keywords
This publication has 19 references indexed in Scilit:
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrenceNature Communications, 2022
- Intraductal patient‐derived xenografts of estrogen receptor α‐positive breast cancer recapitulate the histopathological spectrum and metastatic potential of human lesionsThe Journal of Pathology, 2018
- Early dissemination seeds metastasis in breast cancerNature, 2016
- Accurate Control of 17β-Estradiol Long-Term Release Increases Reliability and Reproducibility of Preclinical Animal StudiesJournal of Mammary Gland Biology and Neoplasia, 2016
- A Preclinical Model for ERα-Positive Breast Cancer Points to the Epithelial Microenvironment as Determinant of Luminal Phenotype and Hormone ResponseCancer Cell, 2016
- Progression from ductal carcinoma in situ to invasive breast cancer: RevisitedMolecular Oncology, 2013
- Disseminated tumor cells in the bone marrow of patients with ductal carcinoma in situInternational Journal of Cancer, 2011
- The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinomaOncogene, 2000
- Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: Synergistic action of oncogenes in vivoCell, 1987